| 000 | 01700 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250517190217.0 | ||
| 264 | 0 | _c20190327 | |
| 008 | 201903s 0 0 eng d | ||
| 022 | _a1365-2249 | ||
| 024 | 7 |
_a10.1111/cei.13087 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPazhouhandeh, M | |
| 245 | 0 | 0 |
_aA systems medicine approach reveals disordered immune system and lipid metabolism in multiple sclerosis patients. _h[electronic resource] |
| 260 |
_bClinical and experimental immunology _c04 2018 |
||
| 300 |
_a18-32 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAutoantibodies _xanalysis |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmune System _xphysiopathology |
| 650 | 0 | 4 |
_aImmunoglobulin G _xblood |
| 650 | 0 | 4 | _aLipid Metabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMultiple Sclerosis _ximmunology |
| 650 | 0 | 4 | _aPeptide Library |
| 650 | 0 | 4 | _aProto-Oncogene Mas |
| 650 | 0 | 4 | _aSystems Analysis |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aSahraian, M-A | |
| 700 | 1 | _aSiadat, S D | |
| 700 | 1 | _aFateh, A | |
| 700 | 1 | _aVaziri, F | |
| 700 | 1 | _aTabrizi, F | |
| 700 | 1 | _aAjorloo, F | |
| 700 | 1 | _aArshadi, A K | |
| 700 | 1 | _aFatemi, E | |
| 700 | 1 | _aPiri Gavgani, S | |
| 700 | 1 | _aMahboudi, F | |
| 700 | 1 | _aRahimi Jamnani, F | |
| 773 | 0 |
_tClinical and experimental immunology _gvol. 192 _gno. 1 _gp. 18-32 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/cei.13087 _zAvailable from publisher's website |
| 999 |
_c27843878 _d27843878 |
||